<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00502476</url>
  </required_header>
  <id_info>
    <org_study_id>CI06-003</org_study_id>
    <nct_id>NCT00502476</nct_id>
  </id_info>
  <brief_title>Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections</brief_title>
  <acronym>CBET</acronym>
  <official_title>Multicenter Evaluation of The Effectiveness of Source Control With Daily Chlorhexidine Skin Preparation in Reducing Nosocomial Infections Including MRSA and VRE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hunter Holmes Mcguire Veteran Affairs Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centers for Disease Control and Prevention</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sage Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hunter Holmes Mcguire Veteran Affairs Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if daily bathing with chlorhexidine impregnated washcloths will reduce the
      incidence of MRSA and VRE within an Intensive Care Unit (ICU) or ward setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a cluster randomized, crossover-controlled trial with wards as the units of
      randomization. The trial will predominantly take place in ICU's but may include any acute
      care ward that has active surveillance for MRSA and or VRE in place (i.e., Bone Marrow
      transplant units, Oncology wards, etc.) Units will be randomly assigned to utilize two
      bathing routines in a random order. Each bathing routine will be utilized on all admitted
      patients to the unit for a six month study period for a total study duration of 12 months.
      The two bathing routines will include either the use of the Comfort® Bath Washcloth System
      (control) or the use of 2% Chlorhexidine Gluconate Cloth. Randomized units will either start
      with 2% Chlorhexidine Gluconate Cloth for six months and then switch to Comfort™ Bath
      Washcloth for the remaining six month period or the reverse order. Data collection will
      include all surveillance and clinical cultures for MRSA and or VRE and all bloodstream
      infections.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2007</start_date>
  <completion_date type="Anticipated">September 2009</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population, Natural History</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">14000</enrollment>
  <condition>Nosocomial Bacteremia</condition>
  <condition>MRSA Colonization</condition>
  <condition>MRSA Infection</condition>
  <condition>VRE Colonization</condition>
  <condition>VRE Infection</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bathing with Chlorhexidine Impregnated Washcloths</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients admitted to study units during the proposed study interval are eligible
             for inclusion in the study

        Exclusion Criteria:

          -  Patients with known allergies to chlorhexidine gluconate or any other ingredients in
             the product

          -  Patients with burns that include a high percentage of disrupted body surface area

          -  Use in patients undergoing lumbar punctures or contact with the meninges

          -  Patients with large open skin wounds; and

          -  Children less than 18 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael W Climo, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hunter Holmes Mcguire Veteran Affairs Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Edward S Wong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hunter Holmes Mcguire Veteran Affairs Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jane A Cecil, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hunter Holmes Mcguire Veteran Affairs Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kent Sepkowitz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weil Medical College of Cornell University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Trish M Perl, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Debbie Yokoe, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard School of Medicine, Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maureen Bolon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University Feinberg School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dave K Warren, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Loreen Herwaldt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael W Climo, MD</last_name>
    <phone>(804) 675-5018</phone>
    <email>michael.climo@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Edward S Wong, MD</last_name>
    <phone>(804) 675-6792</phone>
    <email>edward.wong@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maureen K Bolon, MD</last_name>
      <phone>312-695-5059</phone>
      <email>m-bolon@NORTHWESTERN.EDU</email>
    </contact>
    <contact_backup>
      <last_name>Farida Siddiqui</last_name>
      <phone>312-926-3693</phone>
      <email>f-siddiqui2@northwestern.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Maureen K Bolon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gary Noskins, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242-1081</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loreen Herwaldt, MD</last_name>
      <phone>319-356-0474</phone>
      <email>loreen-herwaldt@UIOWA.EDU</email>
    </contact>
    <investigator>
      <last_name>Loreen Herwaldt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Trish M Perl, MD, MSc</last_name>
      <phone>410-955-8384</phone>
      <email>tperl@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kathleen Speck</last_name>
      <phone>(410) 614-6206</phone>
      <email>kspeck2@JHMI.EDU</email>
    </contact_backup>
    <investigator>
      <last_name>Trish M Perl, MD, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Debbie Yokoe, MD, MPH</last_name>
      <phone>617-525-2689</phone>
      <email>dyokoe@partners.org</email>
    </contact>
    <investigator>
      <last_name>Debbie Yokoe, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barnes Jewish Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dave K Warren, MD</last_name>
      <email>DWARREN@IM.WUSTL.EDU</email>
    </contact>
    <contact_backup>
      <last_name>Liana Merz</last_name>
      <email>lmerz@im.wustl.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Dave K Warren, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan-Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kent A Sepkowitz, MD</last_name>
      <email>sepkowik@MSKCC.ORG</email>
    </contact>
    <contact_backup>
      <last_name>Kate Gase, MPH</last_name>
      <phone_ext>7814</phone_ext>
      <email>gasek@MSKCC.ORG</email>
    </contact_backup>
    <investigator>
      <last_name>Kent A Sepkowitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gianna Zucotti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hunter Holmes McGuire Veteran Affairs Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael W Climo, MD</last_name>
      <phone>804-675-5018</phone>
      <email>michael.climo@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Edward S Wong, MD</last_name>
      <phone>(804) 675-6792</phone>
      <email>edward.wong@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Michael W Climo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edward S Wong, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jane A Cecil, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2007</study_first_submitted>
  <study_first_submitted_qc>July 16, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2007</study_first_posted>
  <last_update_submitted>August 6, 2007</last_update_submitted>
  <last_update_submitted_qc>August 6, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2007</last_update_posted>
  <keyword>MRSA</keyword>
  <keyword>VRE</keyword>
  <keyword>BSI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Bacteremia</mesh_term>
    <mesh_term>Cross Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

